Peng et al. (2022) proposed an electrochemical biosensor controlled by dual recognition, through the interaction between two aptamers and two breast cancer tumor cell surface proteins (MCF-7), mucin 1 (MUC1), and adhesion molecules of epithelial cells (EpCAMs), to improve the accuracy of the device [117]. Here, MUC1 is linked to neoplasm.